Antonella Tomassetti

Via G. Amadeo 42
Milan, 20133, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Reduced sulfatide content in deferoxamine-induced senescent HepG2 cells.

Reduced sulfatide content in deferoxamine-induced senescent HepG2 cells.

Journal: The international journal of biochemistry & cell biology

Published: November 14, 2022

Biological and clinical impact of membrane EGFR expression in a subgroup of OC patients from the phase IV ovarian cancer MITO-16A/MANGO-OV2A trial.

Biological and clinical impact of membrane EGFR expression in a subgroup of OC patients from the phase IV ovarian cancer MITO-16A/MANGO-OV2A trial.

Journal: Journal of experimental & clinical cancer research : CR

Published: August 26, 2022

Editorial to the Special Issue "Activations of Cadherin Signaling in Cancer".

Editorial to the Special Issue "Activations of Cadherin Signaling in Cancer".

Journal: International journal of molecular sciences

Published: June 10, 2022

Impairment of RAD17 Functions by miR-506-3p as a Novel Synthetic Lethal Approach Targeting DNA Repair Pathways in Ovarian Cancer.

Impairment of RAD17 Functions by miR-506-3p as a Novel Synthetic Lethal Approach Targeting DNA Repair Pathways in Ovarian Cancer.

Journal: Frontiers in oncology

Published: April 19, 2022

Validation of MiROvaR, a microRNA-based predictor of early relapse in early stage epithelial ovarian cancer as a new strategy to optimise patients' prognostic assessment.

Validation of MiROvaR, a microRNA-based predictor of early relapse in early stage epithelial ovarian cancer as a new strategy to optimise patients' prognostic assessment.

Journal: European journal of cancer (Oxford, England : 1990)

Published: September 02, 2021

Choline kinase alpha impairment overcomes TRAIL resistance in ovarian cancer cells.

Choline kinase alpha impairment overcomes TRAIL resistance in ovarian cancer cells.

Journal: Journal of experimental & clinical cancer research : CR

Published: September 22, 2020

A Cell-Autonomous Oncosuppressive Role of Human RNASET2 Affecting ECM-Mediated Oncogenic Signaling.

A Cell-Autonomous Oncosuppressive Role of Human RNASET2 Affecting ECM-Mediated Oncogenic Signaling.

Journal: Cancers

Published: January 22, 2019

One-Carbon Metabolism: Biological Players in Epithelial Ovarian Cancer.

One-Carbon Metabolism: Biological Players in Epithelial Ovarian Cancer.

Journal: International journal of molecular sciences

Published: June 12, 2018

Simultaneous E-cadherin and PLEKHA7 expression negatively affects E-cadherin/EGFR mediated ovarian cancer cell growth.

Simultaneous E-cadherin and PLEKHA7 expression negatively affects E-cadherin/EGFR mediated ovarian cancer cell growth.

Journal: Journal of experimental & clinical cancer research : CR

Published: March 22, 2018

Axl in ovarian cancer: a step forward for clinical breakthrough?

Axl in ovarian cancer: a step forward for clinical breakthrough?

Journal: Oncotarget

Published: November 24, 2016

Guidance of Signaling Activations by Cadherins and Integrins in Epithelial Ovarian Cancer Cells.

Guidance of Signaling Activations by Cadherins and Integrins in Epithelial Ovarian Cancer Cells.

Journal: International journal of molecular sciences

Published: July 14, 2016

Computational and Immunohistochemical Analyses Highlight AXL as a Potential Prognostic Marker for Ovarian Cancer Patients.

Computational and Immunohistochemical Analyses Highlight AXL as a Potential Prognostic Marker for Ovarian Cancer Patients.

Journal: Anticancer research

Published: May 22, 2016

Showing 1-12 of 22

Last Updated: 09/26/2026